Indian Pharmacopoeia Commission (IPC) Organises First-Ever Interactive Meeting with CDL Kolkata to Promote Quality of Medicines

The Indian Pharmacopoeia Commission (IPC) organized its first-ever interactive meeting with the Central Drugs Laboratory (CDL) and Central Cosmetics Laboratory (CCL) in Kolkata to discuss pharmacopoeial standards and drug quality. Titled “IP 2026: Perspectives, Suggestions & Way Forward,” the meeting focused on assuring the quality, safety, and efficacy of pharmaceuticals. A key highlight was the launch of seven Indian Pharmacopoeia Nitrosamine Impurities Reference Standards to aid in accurate detection, quality assurance, and regulatory compliance. These standards target genotoxic nitrosamine impurities that can occur unintentionally in pharmaceuticals used for conditions like hypertension, diabetes, and tuberculosis.